CYCLIN-DEPENDENT KINASE 6

Clinical trials for CYCLIN-DEPENDENT KINASE 6 explained in plain language.

Never miss a new study

Get alerted when new CYCLIN-DEPENDENT KINASE 6 trials appear

Sign up with your email to follow new studies for CYCLIN-DEPENDENT KINASE 6, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Could a targeted drug delay prostate cancer progression?

Disease control Ongoing

This phase 3 trial tests whether adding the targeted drug abemaciclib to standard hormone therapy (abiraterone plus prednisone) can delay cancer growth in men with high-risk prostate cancer that has spread to bones or organs. Participants receive either abemaciclib or a placebo a…

Matched conditions: CYCLIN-DEPENDENT KINASE 6

Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Jul 02, 2026 03:00 UTC

CYCLIN-DEPENDENT KINASE 6

Get alerted when new CYCLIN-DEPENDENT KINASE 6 trials appear

Could a targeted drug delay prostate cancer progression?